BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 223923)

  • 1. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines.
    van Wezel AL; van Herwaarden JA; van de Heuvel-de Rijk EW
    Dev Biol Stand; 1979; 42():65-9. PubMed ID: 223923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines.
    van Wezel AL; van Steenis G; Hannik CA; Cohen H
    Dev Biol Stand; 1978; 41():159-68. PubMed ID: 223908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present state and developments in the production of inactivated poliomyelitis vaccine.
    van Wezel AL
    Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
    Pay TW; Boge A; Menard FJ; Radlett PJ
    Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of an inactivated rabies vaccine in primary dog kidney cells.
    van Wezel AL; van Steenis G
    Dev Biol Stand; 1978; 40():69-75. PubMed ID: 98375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence and quantification of cell substrate DNA in inactivated poliovirus vaccine.
    Crainic R; Horodniceanu F; Barme M
    Dev Biol Stand; 1980; 46():275-9. PubMed ID: 6245003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monkey kidney cell growth optimization and poliovirus propagation in microcarrier culture.
    Mered B; Albrecht P; Hopps HE; Petricciani JC; Salk J
    Dev Biol Stand; 1981; 47():41-53. PubMed ID: 6262160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of poliovirus obtained from human diploid cells by means of DEAE-Sepharose.
    Horodniceanu F; Panon G; Le Fur R; Barme M
    Dev Biol Stand; 1979; 42():75-80. PubMed ID: 223925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control on the absence of DEAE-polysaccharides in DEAE-sephadex purified poliovirus suspensions by pyrolysis mass spectrometry.
    Windig W; Haverkamp J; van Wezel AL
    Dev Biol Stand; 1981; 47():169-77. PubMed ID: 6164585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification, potency and immunogenicity analysis of Vero cell culture-derived rabies vaccine: a comparative study of single-step column chromatography and zonal centrifuge purification.
    Prem Kumar AA; Mani KR; Palaniappan C; Bhau LN; Swaminathan K
    Microbes Infect; 2005 Jul; 7(9-10):1110-6. PubMed ID: 16046167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of rabies antigen by ELISA.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration and purification of poliovirus by immune adsorption on immobilized antibodies.
    van der Marel P; van Wezel AL; Hazendonk AG; Kooistra A
    Dev Biol Stand; 1980; 46():267-73. PubMed ID: 6245002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New trends in the preparation of cell substrates for the production of virus vaccines.
    van Wezel AL
    Prog Immunobiol Stand; 1971; 5():187-92. PubMed ID: 4349819
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification and concentration of rabies virus by chromatography on chemically modified porous silicates.
    Krasilnikov IV; Aksenova TA; Mchedlishvili BV
    Acta Virol; 1981 Jul; 25(4):205-12. PubMed ID: 6116414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; MourĂ£o-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-specific antibody response in human peripheral blood lymphocytes in vitro by a dog kidney cell vaccine against rabies virus (DKCV).
    Uytdehaag FG; Osterhaus AD; Loggen HG; Bakker RH; van Asten JA; Kreeftenberg JG; van der Marel P; van Steenis B
    J Immunol; 1983 Sep; 131(3):1234-9. PubMed ID: 6193180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monitoring of antigen levels during inactivated poliovirus vaccine production: evaluation of filtration techniques.
    Moynihan M; Petersen I
    Dev Biol Stand; 1981; 50():243-8. PubMed ID: 6804290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
    Kallel H; Rourou S; Majoul S; Loukil H
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Zonal centrifuge purification of human rabies vaccine obtained on bovine foetal kidney cells (author's transl)].
    Atanasiu P; Tsiang H; Lavergne M; Chermann JC
    Ann Microbiol (Paris); 1977; 128(2):297-302. PubMed ID: 563208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tissue-culture, modified live-virus rabies vaccine for dogs: report on development and clinical trial.
    Emery JB; Elliott AY; Bordt DE; Burch GR; Kugel EE
    J Am Vet Med Assoc; 1968 Mar; 152(5):476-82. PubMed ID: 5637640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.